Nonprofit · EIN 41-1688677
INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY
Tax-exempt · WASHINGTON, DC 20045
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $3,252,371 | $3,825,342 | -$572,971 | $3,998,836 | $716,461 | $3,282,375 |
| June 30, 2024 | 990 | $2,620,637 | $2,057,754 | $562,883 | $4,579,976 | $826,946 | $3,753,030 |
| June 30, 2023 | 990 | $2,385,393 | $2,953,759 | -$568,366 | $3,943,001 | $980,587 | $2,962,414 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $3,127,773
- Investment income
- $124,598
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $150,716
- Salaries, compensation and benefits (total)
- $0
- Professional fundraising fees
- $0
- Accounting fees
- $23,553
- Occupancy
- $516,569
- Travel
- $54,625
- Program services (functional)
- $2,386,589
- Management and general (functional)
- $1,438,753
Balance sheet and other
- Total assets, start of year
- $4,579,976
- Total assets, end of year
- $3,998,836
- Total liabilities, end of year
- $716,461
- Net assets, end of year
- $3,282,375
- Publicly traded securities
- $3,102,192
- Net assets without donor restrictions
- $3,189,952
- Net assets with donor restrictions
- $92,423
- Gross receipts
- $3,252,371
- Employees
- 0
- Volunteers
- 91
- Year formed
- 1989
- State of legal domicile
- NJ
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Mette Norgaard | Director Trustee or director | 1 | $0 |
| Jeremy Rassen | Director Trustee or director | 1 | $0 |
| Stanley Edlavitch | Executive Director Emeritus Trustee or director | 1 | $0 |
| Christopher Rentsch | Director Trustee or director | 1 | $0 |
| Kristian Filion | Director Trustee or director | 1 | $0 |
| Stine Hasling Mogensen | Director Trustee or director | 1 | $0 |
| Daniela Moga | Director Trustee or director | 1 | $0 |
| Yoshiaki Uyama | Director Trustee or director | 1 | $0 |
| Juan Hincapie-Castillo | Director Trustee or director | 1 | $0 |
| Andrea Margulis | Director Trustee or director | 1 | $0 |
| Efe Eworuke | Director Trustee or director | 1 | $0 |
| Gillian Caughey | Director Trustee or director | 1 | $0 |
| Jessica Franklin | Director Trustee or director | 1 | $0 |
| Keiko Asao | Director Trustee or director | 1 | $0 |
| Marianne Cunnington | Director Trustee or director | 1 | $0 |
5 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Elizabetta Patorno | Director Trustee or director | 1 | $0 |
| Jennifer Christian | VP Finance Trustee or director, Officer | 20 | $0 |
| Lisa Pont | Immediate Past President Trustee or director, Officer | 2 | $0 |
| Ursula Kirchmayer | President-Elect Trustee or director, Officer | 2 | $0 |
| Mary Beth Ritchey | President Trustee or director, Officer | 2 | $0 |
990 for the year ended June 30, 2024: 23 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Andrea Margulis | Director Trustee or director | 1 | $0 |
| Efe Eworuke | Director Trustee or director | 1 | $0 |
| Hongbo Yuan | Director Trustee or director | 1 | $0 |
| Daniel Prieto-Alhambra | Director Trustee or director | 1 | $0 |
| Yoshiaki Uyama | Director Trustee or director | 1 | $0 |
| Marianne Cunnington | Director Trustee or director | 1 | $0 |
| Elisabetta Patorno | Director Trustee or director | 1 | $0 |
| Keiko Asao | Director Trustee or director | 1 | $0 |
| Gillian Caughey | Director Trustee or director | 1 | $0 |
| Jessica Franklin | Director Trustee or director | 1 | $0 |
| Stine Hasling Mogensen | Director Trustee or director | 1 | $0 |
| Ursula Kirchmayer | Director Trustee or director | 1 | $0 |
| Stanley Edlavitch | Executive Director Emeritus Trustee or director | 1 | $0 |
| Jeremy Rassen | Director Trustee or director | 1 | $0 |
| Jennifer Lund | Director Trustee or director | 1 | $0 |
| Mette Norgaard | Director Trustee or director | 1 | $0 |
| Mary Beth Ritchey | President-Elect Trustee or director, Officer | 2 | $0 |
| Vincent Lo Re | Immediate Past President Trustee or director, Officer | 2 | $0 |
| Jennifer Christian | VP Finance-Elect Trustee or director, Officer | 2 | $0 |
| Caitlin Knox | VP Finance Trustee or director, Officer | 2 | $0 |
| Tobias Gerhard | Immediate Past President Trustee or director, Officer | 2 | $0 |
| Lisa Pont | President Trustee or director, Officer | 2 | $0 |
| Jennifer Christian | Executive Secretary Officer | 20 | $0 |
990 for the year ended June 30, 2023: 21 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| Andrea Margulis | Director Trustee or director | 1 | $0 |
| Hongbo Yuan | Director Trustee or director | 1 | $0 |
| Stanley Edlavitch | Executive Director Emeritus Trustee or director | 1 | $0 |
| Ursula Kirchmayer | Director Trustee or director | 1 | $0 |
| Daniel Prieto-Alhambra | Director Trustee or director | 1 | $0 |
| Yoshiaki Uyama | Director Trustee or director | 1 | $0 |
| Jennifer Lund | Director Trustee or director | 1 | $0 |
| Stine Hasling Mogensen | Director Trustee or director | 1 | $0 |
| Tomoko Kobayashi | Director Trustee or director | 1 | $0 |
| Mette Norgaard | Director Trustee or director | 1 | $0 |
| Jessica Franklin | Director Trustee or director | 1 | $0 |
| Gillian Caughey | Director Trustee or director | 1 | $0 |
| Shirley Wang | Director Trustee or director | 1 | $0 |
| Montserrat Soriano Gabarro | Director Trustee or director | 1 | $0 |
| Jeremy Rassen | Director Trustee or director | 1 | $0 |
| Efe Eworuke | Director Trustee or director | 1 | $0 |
| Lisa Pont | President-Elect Trustee or director, Officer | 2 | $0 |
| Vincent Lo Re | Immediate Past President Trustee or director, Officer | 2 | $0 |
| Caitlin Knox | VP Finance-Elect Trustee or director, Officer | 2 | $0 |
| Tobias Gerhard | President Trustee or director, Officer | 2 | $0 |
| James Vrac | Executive Secretary Officer | 20 | $0 |
Address and contacts
- Address (IRS master file)
- 529 14TH ST NW STE 1280, WASHINGTON, DC 20045-2205
- In care of
- % JENNIFER CHRISTIAN
- Principal officer (990 for 2024)
- Mary Beth Ritchey, 529 14th St NW STE 1280, Washington, DC 20045
- Signed the 990
- JENNIFER CHRISTIAN, VP Finance
- Phone
- (301) 718-6500
- Website
- www.pharmacoepi.org
- Return prepared by
- Mullins PC
Mission
See Schedule O
Program accomplishments
- Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk management, and other related fields. 2) Convene regular regional and local meetings on scientific and public policy issues, which currently includes a mid-year conference in conjunction with meetings of the board of directors and scientific program committee; and an annual Asian conference (ACPE) partnered with local scientific and professional societies.Expenses $2,326,062 · grants $150,716 · revenue $3,127,773
- The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; and 2) regular email updates to members on developments in pharmacoepidemiology, or about ISPE.Expenses $24,049
- Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.Expenses $15,141
- Membership: With membership of over 2000 in more than 50 countries, the Society is the voice of pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. Members gain access to a rich and formidable network of like-minded individuals entirely focused on these issues, combined with career mentoring and professional development.Expenses $14,857
- The Societys education program delivers: 1) on-demand education sessions of a broad range of topics recorded at ISPE conferences and delivered online via the Education Center; and 2) a regular series of webinars based on current and breaking issues in pharmacoepidemiology presented by leading subject matter experts.Expenses $6,480
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 41-1688677
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (509(a)(2))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1994
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $3,998,836
- Income (IRS master file)
- $3,252,371
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $3,252,371 | $3,825,342 | $3,998,836 | IRS |
| 990 | June 2024 | $2,620,637 | $2,057,754 | $4,579,976 | IRS |
| 990 | June 2023 | $2,385,393 | $2,953,759 | $3,943,001 | XML |
| 990 | June 2022 | $827,522 | $891,957 | $4,224,312 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 41-1688677).
Questions about INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY
- What is the EIN of INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY?
- The employer identification number (EIN) of INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY is 41-1688677.
- Is INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1994.
- Are donations to INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY?
- The 990 for the year ended June 30, 2025 names Mary Beth Ritchey.
- Who are the officers and directors of INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY?
- The 990 for the year ended June 30, 2025 lists 20 people; 0 received compensation from the organization.
- How much revenue does INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $3,252,371, expenses of $3,825,342 and total assets of $3,998,836 at year end.
Other nonprofits in WASHINGTON
- AARP EIN 95-1985500 · last filed 990 for 2024
- RISANT HEALTH INC EIN 92-3467590 · last filed 990 for 2024
- AMERICAN NATIONAL RED CROSS EIN 53-0196605 · last filed 990 for 2025
- GAVI ALLIANCE EIN 98-0593375 · last filed 990 for 2024
- GEORGETOWN UNIVERSITY EIN 53-0196603 · last filed 990 for 2025
- NATIONAL ASSOCIATION OF LETTER CARRIERS EIN 53-0114650 · last filed 990 for 2025
- SMITHSONIAN INSTITUTE EIN 53-0206027 · last filed 990 for 2025
- CHILDRENS HOSPITAL EIN 53-0196580 · last filed 990 for 2025